Thomas Lawrence Holland, MD

Publications

Huang, DB, Corey, GR, Holland, TL, Lodise, T, O'Riordan, W, Wilcox, MH, File, TM, Dryden, M, Balser, B, Desplats, E, and Torres, A. "Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections." International Journal of Antimicrobial Agents 52, no. 2 (August 2018): 233-240.

PMID
29783024
Full Text

Holland, TL, O'Riordan, W, McManus, A, Shin, E, Borghei, A, File, TM, Wilcox, MH, Torres, A, Dryden, M, Lodise, T, Oguri, T, Corey, GR, McLeroth, P, Shukla, R, and Huang, DB. "A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)." Antimicrobial agents and chemotherapy 62, no. 5 (May 2018).

PMID
29530858
Full Text

Huang, DB, O'Riordan, W, Overcash, JS, Heller, B, Amin, F, File, TM, Wilcox, MH, Torres, A, Dryden, M, Holland, TL, McLeroth, P, Shukla, R, and Corey, GR. "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 66, no. 8 (April 2018): 1222-1229.

PMID
29281036
Full Text

Huang, DB, Strader, CD, MacDonald, JS, VanArendonk, M, Peck, R, and Holland, T. "An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria." Open Forum Infectious Diseases 5, no. 2 (February 1, 2018).

Full Text

Holland, TL, and Fowler, VG. "Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST." Lancet (London, England) 391, no. 10121 (February 2018): 634-636.

PMID
29249277
Full Text

Stergiopoulos, S, Calvert, SB, Brown, CA, Awatin, J, Tenaerts, P, Holland, TL, DiMasi, JA, and Getz, KA. "Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 66, no. 1 (January 2018): 72-80.

PMID
29020279
Full Text

Ruopp, MD, Boggan, JC, Holland, TL, Stillwagon, MJ, Govert, JA, and Bae, JG. "Missing the Mark: Inaccuracy of administrative data in identification of hospitalized patients with pneumonia and results of a systematic clinical reclassification process on readmission rates." Journal of Hospital Administration 6, no. 6 (October 16, 2017): 35-35.

Full Text

Neuss, MJ, and Holland, TL. "Digital ischaemia after intra-arterial drug injection." BMJ case reports 2017 (September 25, 2017).

PMID
28951506
Full Text

Clifton, DC, Clement, ME, Holland, TL, Cox, GM, Dicks, KV, and Stout, JE. "Suboptimal HIV Testing Among Patients Admitted With Pneumonia: A Missed Opportunity." AIDS education and prevention : official publication of the International Society for AIDS Education 29, no. 4 (August 2017): 377-388.

PMID
28825862
Full Text

Doernberg, SB, Lodise, TP, Thaden, JT, Munita, JM, Cosgrove, SE, Arias, CA, Boucher, HW, Corey, GR, Lowy, FD, Murray, B, Miller, LG, Holland, TL, and Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG), . "Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64, no. suppl_1 (March 2017): S24-S29. (Review)

PMID
28350900
Full Text

Pages